60 DEGREES PHARMACEUTICALS, INC. Debt Instrument, Face Amount
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Debt Instrument, Face Amount of $10.77 million as of 2022-03-31, per its 10-Q filed 2023-11-20.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentFaceAmount · last filed 2026-03-30
- 2022-03-31: Debt Instrument, Face Amount $10.77M.
- 2020-05-14: Debt Instrument, Face Amount $150.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-03-31 | $10.77M 10-Q · filed 2023-11-20 |
| 2020-05-14 | $150.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |